PATHOGENETIC HETEROGENITY OF MULTIPLE SCLEROSIS: KEY FOR UNDERSTANDING OF THE DISEASE CLINICAL POLYMORPHISM AND INDIVIDUALIZED THERAPY DEVELOPING
- Authors: Khaibullin T.I.1, Khabirov F.А.1, Devlikamova F.I.1, Babicheva N.N.2
-
Affiliations:
- 1) Каzan State Medical Academy of Russian Health Ministry,2) Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan
- Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan
- Issue: Vol XLII, No 1 (2010)
- Pages: 54-65
- Section: Articles
- URL: https://journals.rcsi.science/1027-4898/article/view/13581
- DOI: https://doi.org/10.17816/nb13581
- ID: 13581
Cite item
Full Text
Abstract
About the authors
Timur Ildusovich Khaibullin
1) Каzan State Medical Academy of Russian Health Ministry,2) Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan
Email: timuur@gmail.com
1) Каzan State Medical Academy of Russian Health Ministry,2) Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan
Farit Аhatovich Khabirov
1) Каzan State Medical Academy of Russian Health Ministry,2) Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan1) Каzan State Medical Academy of Russian Health Ministry,2) Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan
Farida Ildusovna Devlikamova
1) Каzan State Medical Academy of Russian Health Ministry,2) Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan1) Каzan State Medical Academy of Russian Health Ministry,2) Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan
Natalya Nikolaevna Babicheva
Republican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of TatarstanRepublican Clinical-and-Diagnostic Centre for demyelinization diseases of Health Ministry of the Republic of Tatarstan
References
- Бойко, А.Н. Патогенетическое лечение рассеянного склероза: настоящее и будущее / А.Н. Бойко, И.Д. Столяров, Т.В. Сидоренко и др. // Журн. неврол. и психиатр. им. С.С. Корсакова. - 2009. - Спец. выпуск «Рассеянный скле- роз» 2. - Т. 109. - С. 90-100.
- Гусев, Е.И. Рассеянный склероз и другие демиелинизирующие заболевания / Е.И. Гусев, И.А. Завали-шин, А.Н. Бойко. - М.: Миклош, 2004. - 540 с.
- Давыдовская, М.В. Нейродегенеративный процесс при рассеянном склерозе и возможные пути его коррекции / М.В. Да-выдовская, А.Н. Бойко, Е.И. Гусев // Журн. неврол. и психиатр. им. С.С. Корсакова. - 2009. - Спец. выпуск «Рассеянный склероз» 2. - Т. 109. - С 44-53.
- Захарченко, М.А. Курс нервных болезней / М.А. За-харченко. - Москва-Ленинград: Государственное издательство, 1930. - 932 с.
- Клинические рекомендации. Неврология и нейрохирургия [под ред. Е.И. Гусева, А.Н. Коновалова, А.Б. Гехт]. - М.: ГЭОТАР-Медиа, 2008. - 368 с.
- Ройт, А. Иммунология. Пер. с англ. / А. Ройт, Дж. Бростофф, Д. Мейл. - М: Мир, 2000. - 592 с.
- Сидоренко, Т.В. Натализумаб: новый препарат для лечения рассеянного склероза. / Т.В. Сидоренко, Е.В. Кольяк, А.Н. Бойко. // Журн. неврол. и психиатр. им. С.С. Корсакова. - 2009. - Спец. выпуск «Рассеянный склероз» 2. - Т. 109. - С.122-129.
- Хондкариан, О.А. Рассеянный склероз / О.А. Хонд-кариан, И.А. Завалишин, О.М. Невская. - М.: Медицина, 1987. - 256 с.
- Association for research in nervous & mental diseases: Volume 2: Multiple sclerosis. - New York, 1921. - 240 p.
- Bitsch, A. Differentiation of multiple sclerosis subtypes: implications for treatment / A. Bitsch, W. Bruck // CNS Drugs. - 2002. - Vol. 16 (6). - P. 405-418.
- Bruck, W. Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis / W. Bruck // J. Neurol. - 2005. - Vol. 252 (5). - P. 10-15.
- Cantorna, M.T. Vitamin D and multiple sclerosis: an update / M.T. Cantorna // Nutrition Reviews. - Vol. 66 (2). - P. 135-138.
- Carson, M.J. CNS immune privilege: hiding in plain sight / M.J. Carson, J.M. Doose, B. Melchior [et al.] // Immunological Reviews. - 2006. - Vol. 213. - P. 48-65.
- Correale, J. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting / J. Correale, A.S. Villa // Autoimmunity. - 2007. - Vol. 40. - P. 148-160.
- Cruse, J.M. Illustrated dictionary of immunology / J.M. Cruse, R.E. Lewis. - CRC Press, 2009. - 762 p.
- Czlonkowska, A. Estrogen and cytokines production - the possible cause of gender differences in neurological diseases / A. Czlonkowska, A. Ciesielska, G. Gromadzka et al. // Current Pharmaceutical Design. - 2005. - Vol. 11. - P. 1017-1030.
- Delgado, S. The role of CD4+ T-cells in the development of MS / S. Delgado, W.A. Sheremata // Neurological Research. - 2006. - Vol. 28. - P. 245-249.
- Franklin, R.J. Remyelination in the CNS: from biology to therapy / R.J. Franklin, C. Ffrench-Constant // Nature neuroscience. - 2008. - Vol. 9. - P. 830-855.
- Genain, C.P. Identification of autoantibodies associated with myelin damage in multiple sclerosis / C.P. Genain, B. Can-nella, S.L. Hauser et al. // Nature Medicine. - 1999. - Vol. 5. - P. 170-175.
- Gilgun-Sherki, Y. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy / Y. Gilgun-Sherki, E. Melamed, D. Offen // J. Neurol. - 2004. - Vol. 251. - P. 261-268.
- Gironi, M. Immunological markers in multiple sclerosis / M. Gironi, A. Bergami, E. Brambilla [et al.] // Neurol. Sci. - 2000. - Vol. 21. - P. 871-875.
- Hafler, D.A. Multiple sclerosis / D.A. Hafler // J. Clin. Invest. - 2004. - Vol. 113. - P. 788-794.
- Hafler, D.A. Multiple sclerosis / D.A. Hafler, J.M. Slavik, D.E. Anderson et al. // Immunological Reviews. - 2005. - Vol. 204. - P. 208-231.
- Hafler, D.A. Immunologic mechanisms and therapy in multiple sclerosis / D.A. Hafler, H.L. Weiner / Immun. Rev. - 1995. - Vol. 144. - P. 75-107.
- Hemmer, B. New concepts in the immunopathogenesis of multiple sclerosis / B. Hemmer, J.J. Archelos, H.P. Hartung // Nature neuroscience. - 2002. - Vol. 3. - P. 291-301.
- Hohlfeld, R. 'Gimme five': future challenges in multiple sclerosis. ECTRIMS Lecture 2009 / Hohlfeld R. // Multiple Sclerosis. - 2010. - Vol. 16 (1). - P. 3-14.
- Kanda, T. Anti-GM1 antibody facilitates leakage in an in vitro blood-nerve barrier model / T. Kanda, T. Iwasaki, M. Ya-mawaki et al. // Neurology. - 2000. - Vol. 55. - P. 585-587.
- Korn, T. Pathophysiology of multiple sclerosis / T. Korn // J. Neurol. - 2008. - Vol. 255 (6). - P. 2-6.
- Lalazar, G. Glycolipids as immune modulatory tools / G. La-lazar, S. Preston, E. Zigmond et al. // Mini Rev. Med. Chem. - 2006. - Vol. 6. - P. 1249-1253.
- Lassmann, H. Recent neuropathological findings in MS - implications for diagnosis and therapy / H. Lassman // J. Neurol. - 2004. - Vol. 251 (4). - P. 2-5.
- Lily, O. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study / O. Lily, J. Palace, A. Vincent // Brain. - 2004. - Vol. 127. - P. 269-279.
- Lucchinetti, C. The pathology of primary progressive multiple sclerosis / C. Lucchinetti, W. Bruck // Multiple Sclerosis. - 2004. - Vol. 10. - P. 23-30.
- Lucchinetti, C. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination / C. Lucchinetti, W. Bruck, J. Parisi et al. // Ann. Neurol. - 2000. - Vol. 47. - P. 707-717.
- Maggs, F.G. The pathogenesis of multiple sclerosis: is it really a primary inflammatory process? / F.G. Maggs, J. Palace // Multiple Sclerosis. - 2004. - Vol. 10. - P. 326-329.
- Martin, R. HLA class I: friend and foe of multiple sclerosis / R. Martin // Nature Medicine. - 2008. - Vol. 14. - P. 1150-1151.
- McDole, J. The role of CD8+ T-cells in lesion formation and axonal dysfunction in multiple sclerosis / J. McDole, A.J. Johnson, I. Pirko // Neurological Research. - 2006. - Vol. 28. - P. 256-261.
- McFarland, H.F. Multiple sclerosis: a complicated picture of autoimmunity / H.F. McFarland, R. Martin // Nature immunology. - 2007. - Vol. 8. - P. 913-919.
- Menge, T. Disease-modifying agents for multiple sclerosis: recent advances and future prospects / T. Menge, M.S. Weber, B. Hemmer et al. // Drugs. - 2008. - Vol. 68. - P. 2445-2468.
- Merrill, J.E. Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease / J.E. Merrill, N.J. Scolding // Neuropathology and Applied Neurobiology. -1999. - Vol. 25. - P. 435-458.
- Neumann, H. Molecular mechanisms of axonal damage in inflammatory central nervous system diseases / H. Neumann // Curr. Opin. Neurol. - 2003. - Vol. 16. - P. 267-273.
- Paz Soldan, M.M. Heterogeneity of pathogenesis in multiple sclerosis: implications for promotion of remyelination / M.M. Paz Soldan, M. Rodriguez // The Journal of Infectious Diseases. - 2002. - Vol. 186 (2). - P. 248-253.
- Podbielska, M. Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis? / M. Podbielska, E.L. Hogan // Multiple Sclerosis. - 2009. - Vol. 15 (9). - P. 1011-1029.
- Rodriguez, M. Effectors of demyelination and remyeli-nation in the CNS: implications for multiple sclerosis / M. Rodriguez // Brain Pathol. - 2007. - Vol. 17. - P. 219-229.
- Schmidt, S. Candidate autoantigens in multiple sclerosis / S. Schmidt // Multiple Sclerosis. - 1999. - Vol. 5. - P. 147-160.
- Sospedra, M. Immunology of multiple sclerosis / M. Sospedra, R. Martin // Annu. Rev. Immunol. - 2005. - Vol. 23. - P. 683-747.
- Stangel, M. Neuroprotection and neuroregeneration in multiple sclerosis / M. Stangel // J. Neurol. - 2008. - Vol. 255 (6). - P. 77-81.
- Steinman, L. Multiple sclerosis: a two-stage disease / L. Stein-man // Nature immunology. - 2001. - Vol. 2. - P. 762-764.
- Steinman, L. Nuanced roles of cytokines in three major human brain disorders / L. Steinman // J. Clin. Invest. - 2008. - Vol. 118. - P. 3557-3563.
- Svejgaard, A. The immunogenetics of multiple sclerosis // Immunogenetics. - 2008. - Vol. 60. - P. 275-286.
- Tesmer, L.A. Th17 cells in human disease / L.A. Tesmer, S.K. Lundy, S. Sarkar et al. // Immunological Reviews. - 2008. - Vol. 223. - P. 87-113.
- Vanderlug, C.L. Epitope spreading in immunemediated diseases: implications for immunotherapy / C.L. Vanderlugt, S.D. Miller // Nature reviews: immunology. - 2002. - Vol. 2. - P. 85-95.
- Vyshkina, T. Autoantibodies and neurodegeneration in MS / T. Vyshkina, B. Kalman // Lab. Inv. -2008. - Vol. 88. - P. 796-807.
- Waxman, S.G. Axonal conduction and injury in multiple sclerosis: the role of sodium channels / S.G. Waxman // Nature Reviews: neuroscience. - 2006. - Vol. 7. - P. 932-941.
- Zaffaroni, M. Biological indicators of the neurodegenerative phase of multiple sclerosis / M. Zaffaroni // Neurol. Sci. - 2003. - Vol. 24 (5). - P. 279-282.